2024's blockbusters: Top 25 drugs by sales
In 2024, Merck's Keytruda continued to dominate with $29.5 billion in sales, growing 18% over 2023's $25 billion in sales.| Drug Discovery and Development
By Brian Buntz | June 23, 2025| Drug Discovery and Development
In 2024, Merck's Keytruda continued to dominate with $29.5 billion in sales, growing 18% over 2023's $25 billion in sales.| Drug Discovery and Development
Just over three-quarters of patients receiving Sanofi and Regeneron’s Dupixent achieved at least a 75% improvement in disease severity.| Drug Discovery and Development
